Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Had potential... I'm out! Ziggy
Just released.... ziggy
BIOLASE LAUNCHES E-COMMERCE SITE TO ENHANCE POSITIVE USER EXPERIENCE AND STREAMLINE THE PURCHASING PROCESS TO CREATE GREATER EFFICIENCIES FOR DENTAL PRACTITIONERS
Source: PR Newswire (US)
LAKE FOREST, Calif., Feb. 27, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers and a company continually focused on improving the dental ecosystem, has launched a new e-commerce website for its U.S. customers.
?
The new website, store.biolase.com, combines a state-of-the-art desktop and mobile-friendly design with "collections" for a unique and modern shopping experience that customers are accustomed to in today's environment. These different collections allow practitioners to quickly locate a product, and they can further refine the search criteria by procedure, laser type, or dental specialty with the click of their mouse or swipe on their mobile phone.
The website gives customers the ability to link their business bank account to their BIOLASE store account and to subscribe to items they buy on a regular basis, giving office staff more time to spend on patient care instead of placing orders. The site will also suggest popular items based on search history as customers browse or complete their purchases.
On a quarterly basis, the BIOLASE store website will spotlight a different BIOLASE dentist, along with helpful tips for some of their favorite procedures. This will enable more customers to quickly be exposed to the additional capabilities of their laser that they may not have previously considered, as well as learn which tips are being used in certain cases by top laser clinicians.
"We expect the new website will generate increased adoption within our laser platform by making it easier to identify the variety of procedural applications the laser can be used for, along with the best tips available for each treatment and procedure," said Steven Sandor, Chief Operating Officer of BIOLASE.
"We're excited to launch this new e-commerce site," said John Beaver, President and CEO of BIOLASE. "We are continually focused on accelerating the dental laser adoption curve, and we believe this improved online shopping experience will help increase our momentum and continue to help laser dentistry become the gold standard of care."
About BIOLASE
BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 302 patented and 28 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. From 1998 through December 31, 2021, BIOLASE has sold over 43,300 laser systems in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.
For updates and information on Waterlase iPlus®, Waterlase Expressâ„¢, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.
BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties, including statements, regarding BIOLASE's expected revenue and revenue growth and beliefs regarding its financial resources. Forward-looking statements can be identified through the use of words such as "may," "might," "will," "intend," "should," "could," "can," "would," "continue," "expect," "believe," "anticipate," "estimate," "predict," "outlook," "potential," "plan," "seek," and similar expressions and variations or the negatives of these terms or other comparable terminology. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect BIOLASE's current expectations and speak only as of the date of this release. Actual results may differ materially from BIOLASE's current expectations depending upon a number of factors. These factors include, among others, the coronavirus (COVID-19) and the effects of the outbreak and actions taken in connection therewith, adverse changes in general economic and market conditions, competitive factors including but not limited to pricing pressures and new product introductions, uncertainty of customer acceptance of new product offerings and market changes, risks associated with managing the growth of the business, and those other risks and uncertainties that are described in the "Risk Factors" section of BIOLASE's most recent annual report filed on Form 10-K filed with the Securities and Exchange Commission. Except as required by law, BIOLASE does not undertake any responsibility to revise or update any forward-looking statements.
For further information, please contact:
EVC Group LLC
Michael Polyviou / Todd Kehrli
(732) 933-2754
mpolyviou@evcgroup.com / tkehrli@evcgroup.com
? View original content to download multimedia:https://www.prnewswire.com/news-releases/biolase-launches-e-commerce-site-to-enhance-positive-user-experience-and-streamline-the-purchasing-process-to-create-greater-efficiencies-for-dental-practitioners-301756155.html
SOURCE BIOLASE, Inc.
?
Copyright 2023 PR Newswire
Just out...should bump the stock!!!
BIOLASE ENTERS THE SKIN RESURFACING MARKET IN THE U.S. WITH THE LAUNCH OF A NEW WATERLASE FRACTIONAL HANDPIECE
Source: PR Newswire (US)
The new handpiece uses advanced, proprietary technology to deliver faster healing and quicker recovery for skin-resurfacing patients
LAKE FOREST, Calif., Feb. 23, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today the U.S. launch of the Waterlase Fractional Handpiece for doctors seeking a faster and more efficient way to perform skin resurfacing.
?
The Waterlase Fractional Handpiece is FDA 510(k) cleared and built on the patented and proven Waterlase iPlus platform, the leading all-tissue laser in the marketplace. The handpiece can deliver both ablative and non-ablative fractional treatments and provides the doctor with control over the depth of penetration with different parameters and treatment techniques. It can create a uniform, one-dimensional pattern of micro-perforations on the tissue surface for maximum efficacy, offering patients comfortable and effective skin resurfacing treatments with faster healing and quicker recovery time. Utilizing BIOLASE's proprietary water spray, no local or topical anesthetic is required for many procedures, and the ergonomic handpiece fits comfortably in either hand, providing doctors with a faster, easy way to deliver skin resurfacing treatments.
"We're very pleased to announce the launch of this state-of-the-art handpiece in the United States, which works with our current Waterlase iPlus platform to deliver faster and more efficient skin resurfacing," said John Beaver, BIOLASE President and Chief Executive Officer. "I believe this launch will further accelerate the adoption of our Waterlase technology in the dental industry and is consistent with our commitment to provide less invasive, patient-friendly technology for both patients and clinicians and expands our access to the approximately $215 million skin resurfacing market worldwide."
This Waterlase Fractional Handpiece is compatible with version 2.1 or newer of the Waterlase iPlus All-Tissue laser and has experienced success to date in international markets. To learn more about the benefits of the Waterlase Fractional Handpiece, visit https://www.biolase.com/fractional-handpiece/.
About BIOLASE
BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 302 patented and 28 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. From 1998 through December 31, 2021, BIOLASE has sold over 43,300 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.
For updates and information on Waterlase iPlus®, Waterlase Expressâ„¢, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.
BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties. Forward-looking statements can be identified through the use of words such as may," "might," "will," "intend," "should," "could," "can," "would," "continue," "expect," "believe," "anticipate," "estimate," "predict," "outlook," "potential," "plan," "seek," and similar expressions and variations or the negatives of these terms or other comparable terminology. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect BIOLASE's current expectations and speak only as of the date of this release. Actual results may differ materially from BIOLASE's current expectations depending upon a number of factors. These factors include, among others, those risks and uncertainties that are described in the "Risk Factors" section of BIOLASE's annual report filed on Form 10-K filed with the Securities and Exchange Commission. Except as required by law, BIOLASE does not undertake any responsibility to revise or update any forward-looking statements.
For further information, please contact:
EVC Group LLC
Michael Polyviou / Todd Kehrli
(732) 933-2754
mpolyviou@evcgroup.com / tkehrli@evcgroup.com
? View original content to download multimedia:https://www.prnewswire.com/news-releases/biolase-enters-the-skin-resurfacing-market-in-the-us-with-the-launch-of-a-new-waterlase-fractional-handpiece-301754078.html
SOURCE BIOLASE, Inc.
?
Copyright 2023 PR Newswire
Time to bump.....ziggy
BIOLASE TO PRESENT AT THE THIRD ANNUAL WINTER WONDERLAND BEST IDEAS VIRTUAL INVESTOR CONFERENCE
Source: PR Newswire (US)
LAKE FOREST, Calif., Feb. 16, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has been invited to present at the Third Annual Winter Wonderland Best Ideas Virtual Investor Conference being held February 21–24, 2023. John Beaver, President and Chief Executive Officer, and Jennifer Bright, Chief Financial Officer, will present at the conference and host virtual meetings with institutional investors and analysts throughout the event.
?
BIOLASE is scheduled to present on Tuesday, February 21, 2023, at 2:00 p.m. PT (5:00 p.m. ET). Management will be available for one-on-one meetings from February 23–24, 2023. The presentation will be webcast live and available for replay at ir.biolase.com.
To receive additional information, request an invitation, or schedule a one-on-one meeting, please email angie.wright@issuerdirect.com.
Investors can register here for the conference.
About BIOLASE
BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 301 patented and 28 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. From 1998 through December 31, 2021, BIOLASE has sold over 43,300 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.
For updates and information on Waterlase iPlus®, Waterlase Expressâ„¢, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.
BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.
For further information, please contact:
EVC Group LLC
Michael Polyviou / Todd Kehrli
(732) 933-2754
mpolyviou@evcgroup.com / tkehrli@evcgroup.com
? View original content to download multimedia:https://www.prnewswire.com/news-releases/biolase-to-present-at-the-third-annual-winter-wonderland-best-ideas-virtual-investor-conference-301749428.html
SOURCE BIOLASE, Inc.
?
Copyright 2023 PR Newswire
Time for another run to .60 to .70....ziggy
Reentry point for me is .50...cheers... Ziggy
Bought at .45 a week ago...sold 2 days ago at .65...have limit rebuy at .50
Wash, rinse, repeat!!!! Cheers.. Ziggy
Interesting day...know your exit strategy! Cheers.. Ziggy
Get in ....get out...good luck!! Ziggy
Solid earnings growth for 2022 eoy reporting!
This could run..real soon!!!
Ziggy
Wow...thus is running today after $9.5 mil offer!!!
This stock getting pummeled last 5 days...is there a short position?
Ziggy
It's sad that a cfo would check out just because of money ... many family members affected by his irrational thought process.
Ziggy
I checked my ameritrade account and options are not available....is this dark money shorting?
This stock has gone from 13 to 6.45 on 3 days....what's driving this?
I can't find any Intel except "profit taking" on this new Hong Kong based financial institution. Stock has lost 50% value in 2 days .
Thoughts????
Not vindictive or bitter...long time ago I was newbie and got caught up in the pump and dump hype....
My interest in cmgr started with the Elon Musk rally.
Just leveling the playing field...okay how about you...what's your interest in cmgr??? ...from $25 to $.001 .
The trend is your friend.
What happened with gronk??? Stock got pushed up to .001 for a couple of days... the back down to current price.
Thoughts.
Your kidding correct?
Show revenue stream last 6 month
Where's Gronk???...other big names????
Show current stock dilution over last 6 months.
( I'll help if needed)
How many employees listed..last I looked was 1.
Stock price @$25 over a year ago was a fluke due to Elon Musk endorsement of a company with similar name ( I remember).
To all newbies.... careful what you wish for!
Caveat emptor..... cheers..ziggy
Time for a run to 15!!!
Thanks for DD....wz
What is driving stock down?
Nice...pop....let's go higher@!!
Ziggy
Why the drop today...the news release seems positive...anyone with Intel wish to educate fellow ihubbers!!!
Ziggy
Nice bounce from yesterday's 56% drop!!!
Ziggy
Great call.....bought in at .7 just sold at 1.00 premarket trading...40% return in a couple of days!!
Cheers..ziggy
Where's Gronk????
Pink slip stock pr notices are not subjected to the legal scrutiny as a Naz or ny exchange stock...nor are their financial statements...time will tell if the gronk pr release adds value to cmgr or not...cheers...ziggy.
Can someone actually post a link were gronk actually talks about his support of cmgr and how he is being compensated for this pr piece....credible links only....cheers...ziggy.
Here is an old post of mine from 2021.
.....March 21st, 2021...cmgr stock price shot to $25 per share... (stock jumped because Elon Musk was supporting a stock called ......"clubhouse media".....investors confused this with cmgr and the stock went viral for 1 hr.) By july 8th, 2021.....cmgr...was $4.50 per share???? Over 80% drop in 3 short months....but all I hear is "good news imminent , pick up cheap shares, great potential, etc.... what do we tell investors that bought at $25 and still holding???
The chart my friend is the trend... this stock is toxic...cut loses and run."
...ziggy
I been posting since Elon Musk confusion push stock up to $26 for a millisecond... just looking out for newbies that might bite on puff piece, pump and dump promoters, pie in the sky predictions...financials are weak..2 billion......... A/S.....I see nothing wrong voicing an option...cheers...ziggy
A/S..... 2 BILLION.
Let see where we are at friday...Secondly....cmgr..was trending south for 6 consecutive months....finally...I believe my previous prediction was for end of summer ??... cheers....ziggy
It would be interesting to find out how Gronk is being compensated for his endorsement of cmgr? I'll bet it's shares!
Secondly...what will gronk bring to the table to generate revenue for cmgr?
Third... yes..."look at the new shiny object!!!!"...prediction of .02..... .05.... .10 a little premature.... let's see what eod.. brings for Friday...let's not forget 2 billion A/S.
Note...I'm not a shorter...just practical...
Caveat emptor...cheers...ziggy
I predict... .001 by end of summer....with a/s at 2 billion....dilution is out if control...caveat emptor...cheers
...ziggy
I do not have PM....but very interesting week to come for amc....maverick appears to be the catalyst!!!
Ziggy
I agree.... look
.......a new shiny object!!!
Caveat emptor....cheers...ziggy
Ditto.....tia...near death experience humbles a person...cheers..ziggy
Musk engagement with twitter..reminds me of revelations 21:5...enjoy...ziggy
Imho ... the devil is in the details...as said before..whether Musk buy twitter is irrelevant...his 9% stake in twitter is enough to have twitter execs look over their shoulders day and night...
A good analogy... musk is like a very righteous man talking to an unclean spirit (twitter execs) ... his name is legion and they were many...to end this man's tortue...he let the spirits (twitter execs) transition in pigs and run off a cliff and drown..(similar to some twitter execs being let go or quitting because their direction does not coincide with the future mission statement of twitter). Ring a bell?
In the stock market..."pigs get fat..hogs get slaughtered"... have a great weekend .
Ziggy
Thanks for the invite but I'm well versed in finance, politics, and chess...
Getting fresh popcorn for the November elections...cheers...ziggy